Home » Topics » BioWorld

BioWorld
RSS

AGOURON FILES FOR 2 MILLION-SHARE OFFERING

Oct. 7, 1991

POTENTIAL 'BLOCKBUSTER' FOR LTIZ

Oct. 7, 1991

ICOS TO CO-DEVELOP DRUGS WITH GLAXO

Oct. 7, 1991

CEL-SCI COMPLETES PRIVATE PLACEMENT

Oct. 7, 1991

ALFACELL EXPANDS ONCONASE TRIALS

Oct. 7, 1991

ONCOSCINT APPROVED IN GERMANY

Oct. 4, 1991

MIXED SIGNALS ON CENTOXIN PROSPECTS

Oct. 4, 1991

DNAP RAISES $28.4 MILLION IN STOCK SALE

Oct. 4, 1991

CLUE TO AIDS VACCINE EFFECTIVENESS

Oct. 4, 1991

SYNERGEN TO SPLIT STOCK 3 FOR 2

Oct. 4, 1991

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 17, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
For clonal hematopoiesis, epigenetics can be in driver’s seat
BioWorld Science
Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...
Gene replacement rescues autism-related phenotypes in mice
BioWorld Science
Autism spectrum disorder (ASD), developmental epileptic encephalopathies and other neurodevelopmental disorders are driven by the disruption of genes regulating...